Across rheumatic diseases

Whole-body MRI in patients with arthralgia or inflammatory arthritis after exposure to immune checkpoint inhibitors: a single-centre prospective imaging study

Lancet RheumatolPublished Prospective imaging study

Authors' conclusion

MRI inflammation and erosions are as prevalent in patients with arthralgia exposed to an immune checkpoint inhibitor as in those with inflammatory arthritis.

Study context

Population
Adults with new musculoskeletal symptoms during or up to 6 months after an ICI, and healthy controls, Leeds, UK60 patients · 20 controls
Participants
35 / 25 / 20
Exposure
Patients with arthralgia or inflammatory arthritis after ICI exposure vs healthy controls
  • Arthralgian = 35
  • Inflammatory arthritisn = 25
  • Healthy controlsn = 20reference
Outcome
Whole-body MRI inflammatory imaging phenotype (joint, tendon, bursal, entheseal and spinal lesions)
Methodological detailssingle-centre, gadolinium contrast-enhanced whole-body MRI, two independent masked assessors
  • Single-centre
  • Gadolinium contrast-enhanced whole-body MRI
  • Two independent masked assessors

Main finding

As reported in the abstract

Whole-body MRI inflammation
Synovitis: acromioclavicular joints
46 [77%] of 60
Synovitis: glenohumeral joints
45 [75%] of 60
Synovitis: wrist
43 [73%] of 59
Synovitis: metacarpophalangeal joints
35 [59%] of 59
Pattern: peripheral inflammatory arthritis
22 (37%) of 60
Pattern: PMR
7 (12%)
Pattern: overlap PMR and peripheral inflammatory arthritis
12 (20%)
Axial inflammation
1 patient

Observational data: associations, not effects.

Further findings

DMARD requirement (6-month follow-up)

Patients requiring DMARD therapy in peripheral inflammatory arthritis pattern
4 of 5
Peripheral inflammatory arthritis pattern had the highest initial and ongoing GC requirement

Original publication

Whole-body MRI in patients with arthralgia or inflammatory arthritis after exposure to immune checkpoint inhibitors: a single-centre prospective imaging study. Lancet Rheumatol. Published 10 June 2025. doi:10.1016/s2665-9913(25)00061-x

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.